Over the Counter

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, join Over the Counter to discuss ongoing developments regarding change in federal vaccine guidance and its impact on measles outbreaks across the US.

Kenzie Hohman, PharmD, and Scott Stoll join Over the Counter to discuss the power of pharmacy advocacy in driving the profession forward and ensuring business sustainability in the future.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, from Harps Food Stores, join Over the Counter to discuss the pharmacist's prescribing authority, real-world proof of why it must expand, and the focus on putting patients back at the center of care.

Rick Couldry, MS/HSPA, joins Over the Counter to discuss the industry's push to cloud-based pharmacy software and how this digital transformation is revolutionizing pharmacy practice and patient safety in real time.

Rae McMahan joins Over the Counter to discuss recent regulatory action involving CVS Caremark and the Federal Trade Commission, exploring what the collection of PBM reform efforts means for the greater pharmacy industry moving forward.

Duane Jones, BS Pharm, joins Over the Counter to discuss the growing evidence of nonopioid therapies for pain management as well as the improved outcomes stemming from the Johns Hopkins Perioperative Pain Program.

Sharon Blank, CEO of Language Scientific and RxTran, joins Over the Counter to discuss the potential dangers of language barriers in medication adherence and how pharmacists can use technology to overcome these barriers.

Richard Dion, PharmD, joins Over the Counter to discuss the emerging prominence of opioid stewardship in health systems' pain management programs and how the necessary role of pharmacists is making a true difference for patients.

Jay Bregman, founder and CEO of Andel, joins Over the Counter to discuss the Medicare GLP-1 Bridge Program and what pharmacists and their patients can expect from the initiative as it rolls out in early July 2026 and beyond.

Esmé Grewal, JD, joins Over the Counter to discuss the often overlooked support LTC pharmacies provide for aging and other vulnerable patient populations.

Lisa Lavin, CEO of Ōmcare, joins Over the Counter to discuss her organization's role in the Rural Health Innovation Initiative and how the Home Health Hub is transforming access to care in rural communities.

Tarah Davis, PharmD, AFMC, joins Over the Counter to discuss her experience as a functional medicine pharmacist and how she addresses gut health to help patients manage the root causes of their disease states.

Harini Bupathi, Esq, joins Over the Counter to discuss PBM audits and how pharmacies can avoid the potential pitfalls often associated with them.

Julia Vu, PharmD, joins Over the Counter to discuss the NCPDP's role in advancing the pharmacy profession through its standards as well as staying up to date on various developments that affect the industry as a whole.

Sandra Leal, PharmD, MPH, joins Over the Counter to discuss the pharmacist's role in team-based diabetes care and how an evolving health care landscape allows for a significant boost in pharmacy-delivered clinical services.

Lisa Miller, PharmD, MSCP, joins Over the Counter to discuss fragmentation in menopause care and how pharmacists are increasingly making themselves known in the women's health space.

Tom DePietro, PharmD, returns to Over the Counter to discuss his experience as an independent pharmacy owner amid constant industry-shaking events occurring throughout recent history.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, join Over the Counter to discuss the modern push toward diabetes care and why the pharmacist's role has never been more important.

Kevin Day, PharmD, joins Over the Counter to discuss his organization, CPESN Ohio, and its new partnership with Humana Healthy Horizons, garnering a new era of value-based care and pharmacy rewards in Ohio pharmacies across the state.

In celebration of World Immunization Week, Nathan Ott, PharmD, joins Over the Counter to discuss the evolution of the pharmacist's role in boosting community vaccination rates across the country.

Mitch Lamb, PharmD, joins Over the Counter to discuss pharmacy accreditation hurdles and why staying consistently proactive can mean the world for a pharmacy's bottom line.

Cencora representatives Matt Sample and Neal Cooper join Over the Counter to discuss the FDA's 7-year push to move national drug codes from 10 to 12 universal digits.

Walgreens Chief Pharmacy Officer Rick Gates joins Over the Counter to discuss his organization's newly introduced hybrid pharmacist role and how it is creating innovation across the greater pharmacy industry.

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, joins Over the Counter to discuss recent comments from FDA Commissioner Marty Makary, MD, MPH, and what they could mean for the pharmacy profession going forward.

William A. Bryson, PharmD, joins Over the Counter for a bonus rendition celebrating Diabetes Alert Day on March 24.

Annie Lambert, PharmD, BCSCP, joins Over the Counter to discuss the safety and scrutiny of compounded GLP-1s and the pharmacist's role in helping patients understand their clinical impact.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, joins Over the Counter to discuss the constant challenges pharmacies are faced with regarding drug shortages as well as the tools and approaches to overcome them.

Matt Sample, senior vice president of manufacturer, quality, and replenishment operations at Cencora, joins Over the Counter to discuss key updates under the DSCSA that independent pharmacies need to look out for in 2026.

Tim Drapeau, CEO of CLIAwaived Inc, joined Over the Counter to discuss the Test Yourself @ Home tool and how it is bridging care gaps between patients, pharmacists, and other providers.

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

Jesse Dresser, Esq, joined Over the Counter to provide necessary insights into recently signed PBM reform set to revolutionize the distribution of pharmacy benefits.

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

Chad Worz, PharmD, BCGP, FASCP, and James Lewis, from the American Society of Consultant Pharmacists (ASCP), joined Over the Counter to discuss the Inflation Reduction Act's industry-wide changes kicking off in 2026.

Meagan Brown, PharmD, BCACP, joined Over the Counter to celebrate National Pharmacist Day and discuss the various avenues for expanding pharmacists' scope.

Susan Thomas, RN, joined Over the Counter to discuss women's health, the pharmacist's role, and her organization's newly launched program designed to benefit both patients and providers.

Jennifer Flynn, CPHRM, joined Over the Counter to discuss pharmacists' potential risks and benefits when using social media for professional or personal purposes.

Kenric B. Ware, PharmD, MBA, AAHIVP, joined Over the Counter to discuss stigmas surrounding HIV care and prevention as well as the pharmacist's role in advancing management of the condition.

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.

Megan Smith, PharmD, joined Over the Counter to discuss continuously updated pneumococcal vaccines and the pharmacist's role among the greater health care community in managing pneumococcal diseases.

John C. Goodman, PhD, joined Over the Counter to discuss TrumpRx and this presidential administration's plans for lowering drug prices in the years to come.

Catie Stimmel, PharmD, joined Over the Counter to discuss the importance of patient safety organizations for the greater health care continuum.

Rick Sage, executive vice president of innovation and standards at NCPDP, joined Over the Counter to discuss the lasting impacts of the government shutdown on pharmacy and how it affected industry processes heading into 2026.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, joined Over the Counter to discuss both state and federal PBM reform heading into the new year.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, joined Over the Counter to discuss pharmacists' roles in improving diabetes outcomes as well as reaching patients in their communities.

Alyssa Mack, PharmD, joined Over the Counter during American Pharmacists Month to discuss how her pharmacy practice has put a focus on increasing clinical services.

Steve Moore, PharmD, joined Over the Counter during American Pharmacists Month to discuss community pharmacy innovations, collaborations, and partnerships driving improved patient outcomes.

Brad Phillips, PharmD, BCACP, joined Over the Counter during American Pharmacists Month to discuss the evolution of pharmacy education amid a rapidly growing expansion of pharmacists' clinical authority.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, joined Over the Counter during American Pharmacists Month to discuss the increased use of technology in pharmacy practice.